首页 | 本学科首页   官方微博 | 高级检索  
     


Use of a counterpulsation balloon as a substitute for the pulmonic valve: a new application
Authors:J Frederiksen  M N Ilbawi  A J Gorman  M Opravil  F S Idriss  J M Moran
Affiliation:1. Department of Surgery, Baylor College of Medicine and Texas Heart Institute, Houston, Tex;2. Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, NY;3. Division of Cardiac Surgery, University of Maryland St Joseph Medical Center, Towson, Md;4. Division of Cardiac Surgery, Department of Surgery, Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, Ohio;5. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md;6. Providence Anesthesiology Associated, Charlotte, NC;7. Division of Cardiac Surgery, Brigham and Women''s Hospital, Harvard Medical School, Boston, Mass;8. Department of Surgery, Heart & Vascular Program, Baystate Health, University of Massachusetts Chan Medical, School–Baystate, Springfield, Mass;1. Division of Cardiac Surgery, Yale School of Medicine, New Haven, Conn;2. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn;1. Department of Surgery, University of Michigan Medical School, Ann Arbor, Mich;2. Department of Surgery, Extracorporeal Life Support Laboratory, University of Michigan Medical School, Ann Arbor, Mich;3. Information School, University of Wisconsin, Madison, Wis;4. Department of Surgery, Section of Transplantation, University of Michigan Medical School, Ann Arbor, Mich;5. Department of Cardiac Surgery, University of Michigan Medical School, Ann Arbor, Mich
Abstract:An inflatable, 3-ml balloon positioned within the distal right ventricular outflow tract was used to restore pulmonic valve function in 8 dogs that had undergone open-chest valvectomy. Balloon inflation and deflation were accomplished with a counterpulsation console. Valvectomy produced loss of the pulmonic incisura, a decrease in pulmonary artery diastolic pressure (PADP; mean +/- standard error) (9.5 +/- 1.3 versus 4.4 +/- 0.6 mm Hg, p less than 0.01), and an increase in pulmonary artery pulse pressure (PAPP) (8.6 +/- 0.7 versus 19.1 +/- 1.9 mm Hg, p less than 0.01) without significantly affecting forward cardiac output (CO) (1,750 +/- 110 versus 1,880 +/- 230 ml/min, p is not significant). Properly timed counterpulsation restored the pulmonic incisura, raised the PADP from 6.1 +/- 0.8 to 9.5 +/- 0.8 mm Hg (p less than 0.01), lowered the PAPP from 15.1 +/- 1.4 to 10.6 +/- 1.0 mm Hg (p less than 0.01), and raised the forward CO from 1,850 +/- 260 to 1,920 +/- 260 ml/min (p less than 0.01). The injection of glass beads, 40 to 150 microns in diameter, into the right ventricular outflow tract increased pulmonary vascular resistance from 383 +/- 87 to 730 +/- 150 dyne . sec cm-5 (p less than 0.05) and decreased forward CO from 1,850 +/- 260 to 1,570 +/- 230 ml/min (p less than 0.05). Following this injection, counterpulsation again restored the pulmonic incisura, raised the PADP from 9.3 +/- 1.4 to 16.0 +/- 1.8 mm Hg (p less than 0.01), lowered the PAPP from 25.0 +/- 2.5 to 18.2 +/- 2.5 mm Hg (p less than 0.01), and raised the forward CO from 1,570 +/- 230 to 1,720 +/- 220 ml/min (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号